These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28574738)

  • 1. Characteristics and Outcome of Male and Female Methadone Maintenance Patients: MMT in Tel Aviv and Las Vegas.
    Adelson M; Linzy S; Peles E
    Subst Use Misuse; 2018 Jan; 53(2):230-238. PubMed ID: 28574738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trend differences over 20 years between two methadone maintenance clinics, one with and one without cannabis legalization.
    Adelson M; Smith D; Peles E
    J Addict Dis; 2021; 39(2):226-233. PubMed ID: 33559536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year and cumulative retention as predictors of success in methadone maintenance treatment: a comparison of two clinics in the United States and Israel.
    Peles E; Linzy S; Kreek M; Adelson M
    J Addict Dis; 2008; 27(4):11-25. PubMed ID: 19042587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological gambling in methadone maintenance clinics where gambling is legal versus illegal.
    Peles E; Schreiber S; Linzy S; Adelson M
    Am J Orthopsychiatry; 2010 Jul; 80(3):311-6. PubMed ID: 20636936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low risk for hepatitis C seroconversion in methadone maintenance treatment.
    Peles E; Schreiber S; Rados V; Adelson M
    J Addict Med; 2011 Sep; 5(3):214-20. PubMed ID: 21844836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in methylphenidate abuse rates among methadone maintenance treatment patients in two clinics.
    Peles E; Schreiber S; Linzy S; Domani Y; Adelson M
    J Subst Abuse Treat; 2015 Jul; 54():44-9. PubMed ID: 25605438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
    Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
    J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of Patients With High Depressive Symptoms on Admission to Methadone Maintenance Treatment.
    Malik E; Adelson M; Sason A; Schreiber S; Peles E
    J Dual Diagn; 2019; 15(4):281-290. PubMed ID: 31530109
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of an implementation of methadone maintenance treatment in China.
    Marienfeld C; Liu P; Wang X; Schottenfeld R; Zhou W; Chawarski MC
    Drug Alcohol Depend; 2015 Dec; 157():60-7. PubMed ID: 26601934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of QTc changes among former opiate addicts since admission to methadone maintenance treatment: benzodiazepine risk.
    Peles E; Linzy S; Kreek MJ; Adelson M
    J Addict Med; 2013; 7(6):428-34. PubMed ID: 24145160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2006 May; 82(3):211-7. PubMed ID: 16219428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and outcome of minority group patients in methadone maintenance treatment.
    Peles E; Schreiber S; Adelson M
    J Psychoactive Drugs; 2014; 46(4):317-24. PubMed ID: 25188702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences and pregnant women in a methadone maintenance treatment (MMT) clinic.
    Peles E; Adelson M
    J Addict Dis; 2006; 25(2):39-45. PubMed ID: 16785218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sense of coherence as a stable predictor for methadone maintenance treatment (MMT) outcome.
    Abramsohn Y; Peles E; Potik D; Schreiber S; Adelson M
    J Psychoactive Drugs; 2009 Sep; 41(3):249-53. PubMed ID: 19999678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic.
    Lister JJ; Brown S; Greenwald MK; Ledgerwood DM
    Subst Abus; 2019; 40(2):185-193. PubMed ID: 30888262
    [No Abstract]   [Full Text] [Related]  

  • 17. Earning "take-home" privileges and long-term outcome in a methadone maintenance treatment program.
    Peles E; Schreiber S; Sason A; Adelson M
    J Addict Med; 2011 Jun; 5(2):92-8. PubMed ID: 21769054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepine usage during 19.5 years in methadone maintenance treatment patients and its relation to long-term outcome.
    Peles E; Adelson M; Schreiber S
    Isr J Psychiatry Relat Sci; 2014; 51(4):285-8. PubMed ID: 25841226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.
    Socías ME; Wood E; Small W; Dong H; Shoveller J; Kerr T; Montaner J; Milloy MJ
    Drug Alcohol Depend; 2016 Nov; 168():211-218. PubMed ID: 27701042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarities and changes between 15- and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) center.
    Peles E; Schreiber S; Sason A; Adelson M
    Drug Alcohol Depend; 2018 Apr; 185():112-119. PubMed ID: 29432974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.